Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sabrina Mühlen

Showing results (21-30 of 28) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 28 results.
Infection and Immunity|November 23, 2016
The Type III Effector NleD from Enteropathogenic Escherichia coli Differentiates between Host Substrates p38 and JNKKristina Creuzburg, Cristina Giogha, Tania Wong Fok Lung, et al.
Antimicrobial Agents and Chemotherapy|February 5, 2020
Identification of Antibiotics That Diminish Disease in a Murine Model of Enterohemorrhagic Escherichia coli InfectionSabrina Mühlen, Isabell Ramming, Marina C Pils, et al.
The EMBO Journal|January 7, 2021
Crystal structure of bacterial cytotoxic necrotizing factor CNF<sub>Y</sub> reveals molecular building blocks for intoxicationPaweena Chaoprasid, Peer Lukat, Sabrina Mühlen, et al.
The FEBS Journal|August 28, 2025
Newly identified properties of known pharmaceuticals and myxobacterial small molecules revealed by screening for autophagy modulatorsJanine Fichtner, Yan Yan Beer, H G Mauricio Ramm, et al.
Plos Pathogens|March 26, 2020
Variations in microbiota composition of laboratory mice influence Citrobacter rodentium infection via variable short-chain fatty acid productionLisa Osbelt, Sophie Thiemann, Nathiana Smit, et al.
Nature Microbiology|January 14, 2017
EspL is a bacterial cysteine protease effector that cleaves RHIM proteins to block necroptosis and inflammationJaclyn S Pearson, Cristina Giogha, Sabrina Mühlen, et al.
Nature|September 13, 2013
A type III effector antagonizes death receptor signalling during bacterial gut infectionJaclyn S Pearson, Cristina Giogha, Sze Ying Ong, et al.
Nature Communications|March 18, 2015
A RIPK2 inhibitor delays NOD signalling events yet prevents inflammatory cytokine productionUeli Nachbur, Che A Stafford, Aleksandra Bankovacki, et al.
Pageof 3

Showing results (21-30 of 28) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 28 results.
Infection and Immunity|November 23, 2016
The Type III Effector NleD from Enteropathogenic Escherichia coli Differentiates between Host Substrates p38 and JNKKristina Creuzburg, Cristina Giogha, Tania Wong Fok Lung, et al.
Antimicrobial Agents and Chemotherapy|February 5, 2020
Identification of Antibiotics That Diminish Disease in a Murine Model of Enterohemorrhagic Escherichia coli InfectionSabrina Mühlen, Isabell Ramming, Marina C Pils, et al.
The EMBO Journal|January 7, 2021
Crystal structure of bacterial cytotoxic necrotizing factor CNF<sub>Y</sub> reveals molecular building blocks for intoxicationPaweena Chaoprasid, Peer Lukat, Sabrina Mühlen, et al.
The FEBS Journal|August 28, 2025
Newly identified properties of known pharmaceuticals and myxobacterial small molecules revealed by screening for autophagy modulatorsJanine Fichtner, Yan Yan Beer, H G Mauricio Ramm, et al.
Plos Pathogens|March 26, 2020
Variations in microbiota composition of laboratory mice influence Citrobacter rodentium infection via variable short-chain fatty acid productionLisa Osbelt, Sophie Thiemann, Nathiana Smit, et al.
Nature Microbiology|January 14, 2017
EspL is a bacterial cysteine protease effector that cleaves RHIM proteins to block necroptosis and inflammationJaclyn S Pearson, Cristina Giogha, Sabrina Mühlen, et al.
Nature|September 13, 2013
A type III effector antagonizes death receptor signalling during bacterial gut infectionJaclyn S Pearson, Cristina Giogha, Sze Ying Ong, et al.
Nature Communications|March 18, 2015
A RIPK2 inhibitor delays NOD signalling events yet prevents inflammatory cytokine productionUeli Nachbur, Che A Stafford, Aleksandra Bankovacki, et al.
Pageof 3